
CNC Earnings Date: Feb 5, 2027 (Estimated) — Centene Corp.
NYSE · Healthcare · Healthcare Plans
Updated
When is CNC's next earnings date?
Centene Corp. (CNC) is expected to report Q4 2026 earnings on Friday, February 5, 2027 at 6:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$1.09 on revenue of $45.58B.
How did CNC do in its last earnings report?
In its most recent report on Oct 27, 2026 (Q3 2026), Centene Corp. posted EPS of $0.58 versus the $0.10 estimate, a beat of 506.1%. Revenue was $50.65B against a $47.12B estimate. The stock's 1-day post-earnings move was +1.0%.
How much does CNC stock move after earnings?
CNC beat EPS estimates in 7 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.2% (up or down) in the day after earnings.
About Centene Corp.
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual and commercial group. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
🤖 AI Earnings Analysis
Centene’s Q3 was mixed: EPS of $0.58 beat estimates by $0.48 and rose from $0.50 year over year, but $6.5B operating losses and a negative margin overshadow the modest revenue increase.
AI-generated summary — powered by BigEarnings.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-27 | Q3 2026 | 0.10 | 0.58 | +506.06% | $50.65B | ✅ Beat | +1.00% | — | — |
| 2026-07-28 | Q2 2026 | 1.02 | 2.51 | +146.08% | $53.58B | ✅ Beat | -0.27% | -0.50% | +1.44% |
| 2026-04-28 | Q1 2026 | 2.08 | 3.37 | +62.02% | $49.94B | ✅ Beat | +13.95% | +23.13% | +35.22% |
| 2026-02-06 | Q4 2025 | -1.23 | -1.19 | +3.25% | $49.73B | ✅ Beat | -3.66% | -1.85% | +8.52% |
| 2025-10-29 | Q3 2025 | -0.18 | 0.50 | +377.78% | $49.69B | ✅ Beat | +12.50% | +8.80% | +18.89% |
| 2025-07-25 | Q2 2025 | 0.41 | -0.16 | -139.02% | $48.74B | ❌ Miss | +6.09% | -2.58% | +9.90% |
| 2025-04-25 | Q1 2025 | 2.54 | 2.90 | +14.17% | $46.62B | ✅ Beat | -6.32% | -3.52% | -8.40% |
| 2025-02-04 | Q4 2024 | 0.49 | 0.80 | +63.27% | $40.80B | ✅ Beat | -5.45% | -9.12% | -8.98% |
Showing last 8 quarters.